Introduction
Obesity is a disease characterized by the accumulation of excessive body fat resulting from intake of high calorie diet, less physical activity and genetic predisposition [1] . Worldwide, the prevalence of obesity has more than doubled since 1980 [2] , leading to secondary chronic diseases like dyslipidemia, cardiovascular diseases, type 2 diabetes and reproductive problems such as infertility [3, 4] . Adverse effects of obesity include low testosterone concentration, altered sperm parameters [5] and hypercholesterolemia [6] , which may ultimately affect male fertility.
The treatment of male infertility involves the use of assisted reproductive techniques, synthetic molecules and herbal drugs. In
Objective: To evaluate the effects of the methanolic extract of Guibourtia tessmannii (G. tesmannii) on sperm parameters, lipid profile and testosterone level in obese rats. Methods: A total of 193 male Wistar rats were fed either with palm oil diet (n=185) or standard diet (n=8) for 16 wk. At the end of this feeding period, 90 obese rats were selected and randomly divided into 18 groups of five rats each and treated with distilled water (10 mL/kg), vitamin E (75 mg/ kg), clomiphene citrate (2 mg/kg) or methanolic extract of G. tessmannii (55, 110 or 220 mg/ kg) for 7, 21 or 56 d. At the end of each treatment period, sperm parameters, lipid profile and testosterone level were evaluated. Data were analyzed using ANOVA for repeated measures followed by post-hoc Tukey HSD (P<0.05) for multiple comparisons. Results: Feeding of rats for 16 wk with palm oil diet significantly damaged sperm parameters. The methanolic extract of G. tesmannii improved sperm viability, motility and normality after 21 or 56 d of treatment. The sperm normality increased significantly in rats treated with the methanolic extract of G. tesmannii for 7 (110 mg/kg, P<0.01) and 56 d (110 and 220 mg/kg, P<0.05) compared to control group. Triglycerids, total cholesterol, low and very low density lipoproteins cholesterol levels were lower in rats treated with the plant extract for 56 d. G. tesmannii also significantly increased the high density lipoprotein cholesterol and testosterone levels in the plasma after 56 d of treatment. Conclusions: The methanolic extract of G. tesmannii can improve sperm parameters, lipid profile and testosterone level in obese rats. These findings may justify the folkloric use of G. tesmannii as a reproductive performance enhancer.
developing countries, the investigation for natural products with less side effects and easy availability is on demand. The plant products are used to treat reproductive problems in many countries and are also proven effective in improving fertility in experimental males.
For example, Moringa oleifera [7] , Panax ginseng [8] , Ficus asperifolia [9] and Allium sativum [10] have all been reported to have sexual function enhancing effects in male rats. Also known as 'Essingang', Guibourtia tessmannii (G. tessmannii) is one of such plants. It's a tall tree (40-50 m) extensively found in tropical Africa and southern America in higher rainfall or evergreen forests. The stem barks of G.
tessmannii are used for the treatment of cardiovascular diseases [11] , some cancers [12] and as aphrodisiacs [13, 14] . Previously, the authors demonstrated the involvement of dopaminergic receptors in the pro-ejaculatory effects of the aqueous and methanolic extracts of G. tesmannii in spinal male rats [15, 16] . In animal model, it has been shown that obesity can be induced by genetic, neuroendocrine or dietary changes [17] . The hypercaloric diet used in the present study is the simplest obesity-induction model, and possibly the one that most closely resembles the reality of obesity in humans [18, 19] . This study was undertaken to evaluate the beneficial effects of the methanolic extract of G. tessmannii on sperm parameters, lipid profile and testosterone level in high fat diet rats. A 15% palm oil diet, which was reported to significantly disrupt the estrus cyclicity in female rats [20] and alter the reproductive performance in male rats [21] , was used in this study.
Materials and methods

Reagents
Assay kits for total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), triglycerids (TG) (CORMAY, Łomianki, POLAND) and testosterone (Accubind, Monobind Inc. Lake Forest, USA) were used. Estradiol, progesterone and eosin were purchased from Sigma Aldrich (St. Louis, MO, USA). All other chemicals and reagents used were of analytical grade and purchased from local suppliers. Estradiol and progesterone were dissolved in ethanol and administered in soya oil while other chemicals were freshly prepared in saline solution. The doses used were selected on the basis of previous studies [15, 21, 22] .
Collection of plant material and preparation of methanolic extract of G. tessmannii
The stem barks of G. tessmannii were collected in February 2015 in Ngoumou, located in Central Cameroon. It was identified by Dr.
Victor Nana and authenticated with the existing Herbarium Voucher specimen 1037/SRFCA in the Cameroon National Herbarium. After shade-drying, the stem barks were grinded and used to prepare the methanolic extract. The stem barks powder of G. tessmannii (300 g) was macerated in methanol (1.5 L) for 72 h. The filtrate was evaporated under reduced pressure to obtain the methanolic extract (34.1 g), with an extraction yield of 11.37%. 
Animals
Induction of obesity and animal partition
Control rats were fed on standard diet (SD) consisted of fats (7%-10%), carbohydrate (68%-70%), protein (18%-20%), vitamins (1%-2%) and minerals (1%-2%). About 15% palm oil was added to the SD to prepare the palm oil diet (POD) [20, 21] . The locally available palm oil used in this study was characterized by a high amount of saturated fat (56%). The chow was mixed with water until it became homogenous in a dough-like consistency. The dough was shaped and used for feeding.
A total of 185 adult male rats were fed with POD for 16 wk. Other rats of the same age (n=8) received SD for the same time lapse.
All rats were weighed twice a week. At the end of 16 wk of POD, increase in body weight (≥15% of initial body weight prior to hyperlipidic diet), hypercholesteremia (≥100 mg/dL) and Lee index (≥300 g) were considered in order to validate the obesity status of each animal [24] . The Lee index was calculated using the following formula: Lee index = [cube root of the body weight (g) / naso-anal length (mm)] × 10 [25] .
After the onset of obesity, obese rats were selected and used for the sexual behavioral study. At the end of the mating test, only 90 obese rats unable of ejaculating within 15 min in the presence of a receptive female, and they were selected for further studies. They were randomly divided into 18 groups comprising five animals each, and treated with distilled water (10 mL/kg), vitamin E (75 mg/kg), clomiphene citrate (2 mg/kg) or methanolic extract of G.
tessmannii (55, 110 or 220 mg/kg) for 7, 21 or 56 d. At the end of each treatment period, rats were sacrificed. Body and sexual organ weights, sperm parameters (motility, viability, normality and count) and sperm morphological abnormalities (abnormal head, abnormal tail, cytoplasmic droplet and tailless head) were evaluated. Lipid profile and testosterone level were also measured in the plasma and testes.
Sexual behavior study
The sexual behavior was monitored by trained observers in a quiet room with a dim red light, around 7 pm as described by Watcho et al [26] . During the study, only estrus female rats (experimentally 
Sperm parameters study
At the end of each treatment period, all rats were anesthetized and killed by cervical dislocation. The cauda epididymis was immediately collected, chopped and placed in saline solution (0.9% NaCl, 5 mL). The fluid was incubated in a water bath (37 ℃, 5 min) to allow sperms to leave the epididymal tubules [27] .
Sperm count
Sperm count was assayed using Mallassez hemocytometer [28] .
Sperm count was expressed as the number of sperms per milliliter of solution.
Sperm motility
Fluid was obtained from the cauda epididymis with a pipette and diluted with Tris buffer solution (2 mL). Immediately after their isolation, sperm motility was evaluated microscopically at 400×magnification as described previously [29] . Sperm forward motility was expressed as a percentage of motile sperms to total sperms counted.
Sperm viability
The ratio of live sperms to dead ones was evaluated using 1% trypan blue staining as previously described [30] . Accordingly, a total number of 200 sperms were counted per slide and the results were expressed as a percentage of the live sperms.
Sperm morphological abnormalities
Percentages of abnormal head, abnormal tail, cytoplasmic droplet and tailless head sperms were determined from a total of 300 sperms per rat in agreement to Bjorndahl et al [31] . Sperm morphology was viewed under light microscope (OLYMPUS, 400×). Data were expressed as percentage of morphologically abnormal sperms to total sperm count.
Collection of tissue and organs
Blood was collected via the abdominal artery for determination of biochemical analysis. The testes, epididymis, vas deferens, ventral prostate and seminal vesicles were removed and their relative weights determined.
Biochemical analysis
TC [32] , HDL-C [32] , low density lipoprotein cholesterol (LDL-C) [33] , very low density lipoprotein cholesterol (VLDL-C) [33] and TG [34] were estimated using standard colorimetric kits (CORMAY, Łomianki, POLAND) [35] 
Statistical analysis
Data were expressed as mean±SEM. The statistical evaluation was performed using STATISTICA (data analyses software system, version 8.0). Significance was calculated by ANOVA for repeated measures followed by the post-hoc Tukey HSD test for multiple comparisons. Significance level was set at P<0.05.
Results
Effects of POD on rats after 16 wk of treatment
As expected, POD rats showed a net body weight gain which was time-dependent ( Figure 1A 
Effects of POD on sperm parameters and sperm morphological abnormalities
In POD rats, the sperm parameters were negatively affected with the most harmful effects recorded for sperm motility, sperm viability and sperm normality. These animals also significantly exhibited sperm abnormal heads, abnormal tails and cytoplasmic droplets. No significant differences were observed in sperm counts and tailless heads (Table 1) .
Effects of methanolic extract of G. tessmannii on body weight
No statistical change in body weight was observed in rats treated with the methanolic extract of G. tessmannii for 7 and 56 d. At the end of 21 d of treatment, the methanolic extract of G. tessmannii at the dose 220 mg/kg induced a significant increase (P<0.05) in body weight compared with distilled water group. On the contrary, when compared with distilled water or vitamin E group, a significant decrease (P<0.05) in the body weight was observed in rats treated with clomiphene citrate after 56 d (Table 2) . 
Effects of methanolic extract of G. tessmannii on genital organ weights
The relative weights of testis and epididymis were significantly (P<0.001) decreased in POD rats compared to SD rats ( Figure 1C ). In animals submitted to POD for 16 consecutive wk, the sperm parameters were seriously damaged when compared to SD values (Table 1) . However, treatment of POD rats with the plant extract significantly (P<0.01) improved the sperm normality, count, motility, and viability at different time points of treatment. Vitamin E and clomiphene citrate produced similar effects ( Figure 3) . 
Sperm morphological abnormalities
The rats in the POD group showed sperm abnormal head, abnormal tail, and cytoplasmic droplet (Table 1) .
After 7 d of treatment, sperm abnormal tail was significantly lowered in the rats treated with clomiphene citrate or methanolic extract of G. tessmannii at all doses ( Figure 4B) . Vitamin E induced a significant decrease in sperm abnormal head, abnormal tail and cytoplasmic droplet ( Figure 4A , B and C).
After 21 d of treatment, sperm abnormal tails were significantly lowered in rats treated with vitamin E, clomiphene citrate or methanolic extract of G. tessmannii at the dose 220 mg/kg ( Figure   4B ).
At the end of 56 d of treatment, the methanolic extract of G.
tessmannii induced a significant decrease in sperm abnormal tail tessmannii (55 mg/kg) ( Table 3) . It is noteworthy mentioning that the improvement of lipid parameters was more effective after 56 d of continuous oral treatment. For instance, the HDL-C was significantly increased in all groups.
Effects on testicular lipids
At the end of 7 d of treatment, HDL-C level was high in rats treated with the methanolic extract of G. tessmannii (55 mg/kg) and vitamin E compared with distilled water (Table 4) . After 21 d of treatment, HDL-C level was also increased in rats treated with the methanolic extract of G. tessmannii (55 mg/kg).
Vitamin E, clomiphene citrate and methanolic extract of G.
tessmannii decreased triglycerides and increased HDL-C level after 56 d of treatment. Moreover, VLDL-C was significantly decreased in rats treated with the methanolic extract of G. tessmannii (Table 5 ).
Effects on plasmatic testosterone
At the end of 21 d of treatment, the methanolic extract of G.
tessmannii (110 mg/kg) significantly increased plasmatic testosterone level compared to distilled water, clomiphene citrate and vitamin E groups (Table 4 ). It was observed that G. tessmannii increased plasmatic testosterone gradually from day 7 to 56 of treatment (Table 5) . Table 5 Effects of vitamin E, clomiphene citrate and methanolic extract of G.
tessmannii on plasmatic testosterone level in obese rats (ng/mL) (n=5). 
Discussion
The present study was undertaken to investigate the effects of the methanolic extract of G. tessmannii on sperm parameters, lipid profile and testosterone level in high fat diet-induced obese rats. The high fat diet used in this study (POD) was effective in promoting obesity, as demonstrated by the significant increase in the growth rate (P<0.05), Lee index (P<0.001) and total cholesterol concentration (P<0.05). After 16 wk of POD exposure, 60.67% of rats were declared obese while 33.33% failed to respond. This difference in response of animals from the same husbandry could be justified by unknown factors including the intraspecific response among those animals [36] . This success in POD-induced obesity is in accordance with previous studies [20, 21, 37, 38] . The hyperlipidic diet used in this study essentially comprised of palm oil (15%) was commonly available in local market. This palm oil contained high percentage Table 3 Effects of vitamin E, clomiphene citrate and methanolic extract of G. tessmannii on plasmatic TC, TG, HDL-C, LDL-C and VLDL-C in obese rats (n=5) of saturated fats (56%). In fact, a high fat diet rich in saturated fat facilitates accumulation of body fat and is considered more deleterious for human health than that rich in unsaturated fat [39] .
Clomiphene citrate and vitamin E were selected as positive controls because of their androgenic [40] and antioxidant [41, 42] The beneficial effects of clomiphene citrate in the improvement of sperm parameters are due to its ability to increase testosterone level [43] . At the level of the hypothalamus, clomiphene citrate competes with circulating estradiol for the estrogen receptors and inhibits the normal negative feedback mechanism, resulting in the high production of GnRH [44] . The high level of GnRH increases the production of FSH and LH by the pituitary gland, leading to the improvement of steroidogenesis and spermatogenesis [40] . It was also observed that the methanolic extract of G. tessmannii significantly increased the weights of sexual organs (epididymis, vas deferens and seminal vesicles) after 56 d of treatment. Similar results were found in male rats treated with extracts of Xylopia aethiopica, Psidium guajava and Syzygium aromaticum [45] [46] [47] . The weight of reproductive organs was particularly regulated by androgens through an increase in the synthesis of proteins and subsequently muscle mass [48] .
Androgens, especially testosterone, thereby contribute to the increased volume and weights of the testes, epididymis and seminal vesicles by stimulating protein synthesis as observed in the present study [49] . The increase observed in these organs could be correlated with the androgenic properties of G. tessmannii.
A study of sperm parameters is an important criterion to evaluate the underlying cause of male infertility [50] . It has been reported that obesity impaired male fertility by decreasing sperm motility, viability and normality as well as increasing sperm morphological abnormalities [5] . In the present study, the methanolic extract of In addition, sperm count was significantly higher in rats treated with vitamin E, clomiphene citrate or G. tessmannii for 7 d. Sperm morphology analysis is an important technic to evaluate male fertility because of its ability to clarify cytotoxic events [51, 52] . In this study, significant decreases in sperm abnormal head, abnormal tail, tailless head and cytoplasmic droplet were observed in rats treated with vitamin E, clomiphene citrate and methanolic extract of G.
tessmannii. These results are in agreement with Saez Lancellotti, et al [53] who reported that olive oil improved sperm parameters in high fat diet rats. In addition, Curcumin and Kolaviron isolated from Curcuma longa and Garcia kola respectively are reported to improve sperm motility and decrease sperm abnormalities by preventing peroxidative changes in the sperm and testicular membranes [54] .
It has been reported that the beneficial effect of vitamin E on the male reproductive system is mainly due to its ability to increase sperm count [55] , sperm motility [56] , sperm viability [57] and fertilizing capacity [56] . The beneficial effect of clomiphene citrate on sperm parameters observed in the present study is in line with the literature reports since it is used to improve sperm parameters in obese individuals with hypoandrogenism by increasing GnRH and LH levels, resulting in an increase in testosterone production [40] .
Lipogenesis up-regulation in POD-induced experimental obesity Table 4 Effects of vitamin E, clomiphene citrate and methanolic extract of G. tessmannii on testicular TC, TG, HDL-C and VLDL-C in obese rats (n=5). leads to increase serum (LDL-C and VLDL-C) concentrations [58] , decrease HDL-C level and affect sperm function in obese rats [59] .
Such reproductive complications of obesity could be lowered when serum lipid concentrations are reduced by hypocholesterolemic drugs. In the present study, the effects of vitamin E, clomiphene citrate and methanolic extract of G. tessmannii on plasma and testicular lipids were more pronounced after 21 and 56 d of treatment. The methanolic extract of G. tessmannii induced a significant decrease in triglyceride level in the plasma and testis after 56 d of treatment. As well, LDL-C and VLDL-C were observed to be significantly lowered in rats treated with vitamin E and methanolic extract of G. tessmannii in the same period. Moreover, HDL-C was significantly higher in rats treated with vitamin E, clomiphene citrate and methanolic extract of G. tessmannii for 56 d. Similarly, the aqueous extract of Eugenia caryophyllus [60] , ethanol extract of Terminalia paniculata bark [61] , polyphenol-rich hydroethanolic extract of Tetrapleura tetraptera spice and Sasa borealis stem extract [62] reduced all lipoproteins except the HDL in high fat dietfed rats.
The increase fat deposit observed in obese patients not only amplifies hypercholesterolemia, but also leads to decrease testosterone concentration [6] and induce oxidative stress [63] . These changes may alter testicular functions and subsequently male fertility by oxidizing membrane spermatozoa [64] and inducing lipid peroxidation, which may affect acrosome reaction and induce infertility [65] . The improvement of sperm parameters by the methanolic extract of G. tessmannii could be justified by the presence of phenols, flavonoids, tannins and terpenoids [66, 67] . Moreover, spectroscopic analysis of the stem bark of G. tessmannii revealed the presence of a dihydrochalcone glucoside 'Asebotin' [68] . The antioxidant properties of Asebotin could be responsible for the beneficial effect of G. tessmannii on sperm production. Apart from the antioxidant properties of G. tessmannii [68, 69] , its androgenic properties could give more information about its fertilizing effects.
Testosterone, the main androgen produced by Leydig cells [70] , controls (at a certain concentration) the initiation and maintenance of spermatogenesis as well as the growth and function of the prostate gland and seminal vesicles [71] . The reduction of sperm concentration and reproductive organ weights in high fat diet-induced obese rats indicate the impairment of male fertility [21] . It has been reported that the first criteria to evaluate spermatogenesis is the size of the testes because the seminiferous tubules and germinal elements constitute about 98% of the total mass of the testis [72] . In the present study, the methanolic extract of G. tessmannii induced a significant increase in plasma testosterone level after 21 and 56 d of treatment. This increase could be attributed to a direct effect of the plant extract on the gonadal tissues or on the hypothalamo-pituitary-testis axis.
Present results are correlated with those reported by Anderson et al, Srikhanth et al and Pahlen [73] [74] [75] .
On the basis of the results obtained in the present study, the therapeutic effect of the methanolic extract of G. tessmannii in PODinduced obese rats may be due to the potency and efficacy of the phytoconstituents present in it. These phytochemical molecules may act synergistically to attain potent biological efficacy. Future studies may lend support for the evidence of biological potency of isolated active phytoconstituents like Asebotin present in the methanolic extract of G. tessmannii.
It can be concluded that the methanolic extract of G. tessmannii improves male fertility by increasing testosterone production and ameliorating sperm parameters (density, viability, normality and motility) in obese rats. The fertility properties of the methanolic extract of G. tessmannii could therefore justify its folkloric use as a reproductive performance enhancer.
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